Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn's Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled Trial.
Saved in:
| Title: | Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn's Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled Trial. |
|---|---|
| Authors: | Reinisch, Walter1 (AUTHOR) walter.reinisch@meduniwien.ac.at, Colombel, Jean-Frederic2 (AUTHOR), D'Haens, Geert R3 (AUTHOR), Rimola, Jordi4 (AUTHOR), Masior, Tomasz5 (AUTHOR), McKevitt, Matt6 (AUTHOR), Ren, Xuehan6 (AUTHOR), Serone, Adrian6 (AUTHOR), Schwartz, David A7 (AUTHOR), Gecse, Krisztina B3 (AUTHOR) |
| Source: | Journal of Crohn's & Colitis. Jun2024, Vol. 18 Issue 6, p864-874. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 18739946 |
|---|---|
| DOI: | 10.1093/ecco-jcc/jjae003 |
